Additionally, LinkedIn's pristine balance sheet and huge cash reserves gave the bulls even more confidence. The bears in the LinkedIn arena claim the company has to execute to perfection in perpetuity to justify the stock's very lofty valuation metrics.
LinkedIn Corp. (LNKD) expanded into China this year, adopting policies in line with the country's censorship rules. Now the world's largest professional social-networking company is saying it may have gone too far.
Following this trend aptly, a shift among LinkedIn Corp (NYSE:LNKD) members is also becoming prominent and its account holders are turning to this platform for gratifying their large and growing demand for professionally-relevant content.
Around midday, three of the top market movers are drug makers AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) and Agios Pharmaceuticals Inc (NASDAQ:AGIO), as well as professional networking site LinkedIn Corp (NYSE:LNKD). Here's a quick roundup of ...